Lucila Kerbauy: Precision Medicine in AML and CAR Cells
Lucila Kerbauy, Head of Cell Therapy Center at Einstein Hospital Israelita, reposted from Larissa Zanetti, on LinkedIn:
“I’m very happy and proud to share another publication from our group on CAR-T cell therapy for acute myeloid leukemia (AML).
A special thank you to our team and collaborators who make this work possible. Advancing innovative and accessible cell therapies in Brazil and beyond is truly a collective effort.”
Quoting Larissa Zanetti’s post:
“It’s out!
I’m very proud to share our recent publication, “Precision Medicine in AML and CAR Cells: Where Are We?” — a collaborative effort uniting two leading research groups from our institution.
In this work, we explore how precision medicine and CAR-based cellular therapies (CAR-T and CAR-NK) are converging to transform the landscape of acute myeloid leukemia (AML) treatment. The review highlights the critical role of patient-specific approaches, novel target discovery, and next-generation cell engineering in shaping the future of personalized immunotherapy.
I truly believe that as the field of advanced cell therapies continues to expand, the integration of precision medicine principles will become increasingly essential.
A huge thank you to my incredible collaborators and mentors who made this work possible.”
Article: Precision medicine with car cells in acute myeloid leukemia: where are we?
Authors: Larissa C. Zanetti, Victoria Tomaz, Ingrid Ferreira de Souza, Paulo V. Campregher, Nelson Hamerschlak, Lucila N. Kerbauy
Read the full article here.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 12, 2026, 11:44Yves Bikorimana: Causes, Diagnosis, and Management of Neonatal Alloimmune Thrombocytopenia
-
Mar 12, 2026, 11:33Kymentie Ferdinande: New Insights Into Platelet Function and Thrombus Formation in Cirrhosis
-
Mar 12, 2026, 11:17Tareq Abadl: Why Do Some People Bruise And Bleed So Easily?
-
Mar 12, 2026, 11:15Matthew Flick: The Interplay of the Fibrinogen αC-Region, Hypofibrinogenemia, and GPVI in Arterial Thrombosis
-
Mar 12, 2026, 11:08Stephen Twumasi: The Impact of Hepatitis B Infection on the Coagulation System During Pregnancy
-
Mar 12, 2026, 11:05Robert Lufkin: One Minute of Wisdom from Robert Lustig on Cholesterol, Sugar, and Heart Disease
-
Mar 12, 2026, 10:36Cynthia Dunbar: Retiring From NIH After 39 Years to Advance Advocacy and Research in Hematology
-
Mar 11, 2026, 23:05Ney Carter Borges: A Safety Advantage of Apixaban over Rivaroxaban Without Clear Superiority
-
Mar 11, 2026, 22:01The Results of Landmark COBRRA Trial in Acute VTE Management – ISTH